Cost-Effectiveness of Culmerciclib Plus Fulvestrant for Previously Treated HR-Positive/HER2-Negative Advanced Breast ...
Introduction Breast cancer (BC) remains a leading driver of cancer morbidity and mortality among women worldwide. In 2022, an estimated 2.3 million new cases and approximately 666,000 deaths from female BC were reported globally, and the burden is …